07/22/2021 | Press release | Distributed by Public on 07/22/2021 01:18
Reig Jofre reinforces its international investment in the United Kingdom, with the acquisition of 49% of the capital, which the Spanish Company for Development Financing (COFIDES, SA) owned in REIG JOFRE UK LTD, since 2015.
In 2014, Reig Jofre incorporated REIG JOFRE UK LTD to develop its business units in the United Kingdom and advance its strategic plan for international growth.
In 2015, the joint state and privately owned COFIDES, which provides financial support for investment projects of Spanish companies in foreign countries, subscribed 49% of the capital of the company through the State funds for Investments Abroad (FIEX) of the Spanish Ministry of Industry, Trade and Tourism.
COFIDES' support made possible to consolidate Reig Jofre presence in the British market and acquire a portfolio of dermatological medicines, integrated into the Specialty Pharmacare division, with widely established brands in the United Kingdom such as Synalar and Metosyn, used in skin infections, psoriasis or inflammatory conditions such as eczema and dermatitis, as well as Crystacide, Hydrogen Peroxide cream, recommended by NICE (National Institute for Clinical Excellence) as first-line treatment for impetigo in Adults and Children.